‘Life-Changing’ Psychedelics, for When Life Is Ending

A recent article from the New York Times interviewed the people who are turning to psilocybin, ketamine and other treatments for palliative care.

Facing a terminal diagnosis can bring overwhelming anxiety and existential distress. This article explores the transformative potential of psilocybin and ketamine therapy for palliative care, sharing deeply moving stories like that of Barry Blechman, an 81-year-old cancer patient who found profound peace and clarity after psilocybin treatment. Discover how these therapies are reshaping end-of-life experiences and offering new hope in ways traditional treatments cannot.

Read the full story:

Previous
Previous

Ketamine for Mental Health: Insights from the Huberman Lab Podcast

Next
Next

Depressed Medical Professionals Took Psychedelics — and It Helped